Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Giuseppe Cetta"'
Publikováno v:
Amino Acids. 35:739-752
Here we summarized what is known at the present about function, structure and effect of mutations in the human prolidase. Among the peptidases, prolidase is the only metalloenzyme that cleaves the iminodipeptides containing a proline or hydroxyprolin
Autor:
Chiara Tani, Antonio Rossi, Anna Lupi, Luca Bini, Benedetta Gualeni, Antonella Forlino, Giuseppe Cetta, Elena Campari, Alessandro Armini, Laura Bianchi, Joan C. Marini
Publikováno v:
PROTEOMICS. 7:1877-1891
This study used proteomic and transcriptomic techniques to understand the molecular basis of the phenotypic variability in the bone disorder osteogenesis imperfecta (OI). Calvarial bone mRNA expression was evaluated by microarray, real-time, and comp
Autor:
Giuseppe Cetta, Bice Conti, Simona Viglio, Ida Genta, Begona Casado, Laura Annovazzi, Paola Perugini, Chiara Zanone, Paolo Iadarola
Publikováno v:
Journal of Chromatography B. 832:1-8
The aim of the present article is to review the efforts performed in the past two decades by numerous research groups for the development of methods that allow a correct diagnosis of prolidase deficiency (PD), a rare autosomal recessive disorder and
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1744(2):157-163
Prolidase deficiency (PD) is a recessive disorder of the connective tissue caused by mutations in the prolidase, a specific peptidase, cleaving the dipeptides with a C-terminal prolyl and hydroxyprolyl residue. PD is a complex syndrome characterized
Autor:
Vittorio Bellotti, Palma Mangione, Antonio Rossi, Giuseppe Cetta, Alessandra Corazza, Monica Stoppini, Giampaolo Merlini, Gennaro Esposito, Sara Raimondi, Paolo Viglino, Sara Marini, Sofia Giorgetti
Publikováno v:
Protein Science. 14:696-702
It has been claimed that beta2-microglobulin (beta2-m) interacts with type I and type II collagen, and this property has been linked to the tissue specificity of the beta2-m amyloid deposits that target the osteo-articular system. The binding paramet
Autor:
Paolo Iadarola, Giuseppe Cetta, James N. Baraniuk, Laura Annovazzi, Begona Casado, Chiara Zanone, Maurizio Luisetti, Simona Viglio
Publikováno v:
ELECTROPHORESIS. 26:752-766
Human urine plays a central role in clinical diagnostic being one of the most-frequently used body fluid for detection of biological markers. Samples from patients with different diseases display patterns of biomarkers that differ significantly from
Autor:
Fabio Pecora, Giuseppe Cetta, Paolo Iadarola, Vitaliano Cattaneo, Laura Annovazzi, C. Rota, Chiara Zanone, Simona Viglio, Eleonora Perani, Maurizio Silvestri
Publikováno v:
ELECTROPHORESIS. 25:1255-1263
Tobacco smoke is involved in the pathogenesis of cardiovascular and respiratory diseases and also has a local toxic effect in the oral cavity. Low-aliphatic aldehydes, such as formaldehyde, acetaldehyde and acrolein, are among the main components of
Autor:
Paola Perugini, Franca Pavanetto, Begona Casado, Paolo Iadarola, Anna Lupi, Ida Genta, Giuseppe Cetta, Tiziana Modena, Bice Conti
Publikováno v:
Journal of Pharmacy and Pharmacology. 56:597-603
Prolidase deficiency (PD) is a rare autosomal recessive disorder caused by inadequate levels of the cytosolic exopeptidase prolidase (E.C. 3.4.13.9), for which there is not, as yet, a resolutive cure. We have investigated whether biodegradable micros
Autor:
Simona Viglio, Laura Annovazzi, James N. Baraniuk, Maurizio Luisetti, Paolo Iadarola, Eleonora Perani, Begona Casado, Giuseppe Cetta
Publikováno v:
ELECTROPHORESIS. 25:683-691
Among various biomarkers believed to behave as descriptors of the disease process in chronic obstructive pulmonary disease (COPD), urinary desmosines are commonly used for monitoring elastin degradation. Given the low concentrations of urinary desmos
Autor:
Angelo Gallanti, Cesare Piacentini, C. Rota, Giulio Rasperini, Maurizio Silvestri, Antonella Forlino, Giuseppe Cetta, Vitaliano Cattaneo
Publikováno v:
Journal of Periodontal Research. 38:568-574
Background: Several clinical trials have shown the effectiveness of Emdogain® (EMD) in promoting tissue regeneration, even though the underlining biological mechanism is still poorly known. Objectives: The aim of the present study was to verify the